We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7984:TSEKokuyo Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

¥831.70

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Kokuyo Co., Ltd. is trading at ¥831.7, well below its 20‑day SMA of ¥883.8 and the 50‑day SMA of ¥900.3, indicating a short‑term price weakness despite a neutral trend direction. The RSI of 32.2 points to oversold conditions, while the MACD histogram remains negative, signaling bearish momentum. Support sits at ¥818.7, just below today’s price, and the next resistance is near ¥975, giving a limited upside corridor. Volatility is elevated at 28.6% over the past 30 days, but the beta of 0.31 suggests the stock moves less than the broader market. Fundamentally, the company posts an 8.7% revenue growth rate, a solid cash pile of ¥110.7 bn, and a modest debt‑to‑equity of 1.36, yet the DCF fair value of ¥436.6 flags a substantial overvaluation relative to the current price. The PE ratio of 17.2 is well under the industry average of 29.1, and the forward PE of 3.9 underscores strong earnings expectations, complemented by a 2.95% dividend yield and a 50.7% payout ratio, which appear sustainable. The market sentiment leans toward “Greed” with a Fear‑Greed Index of 72.9, suggesting investors are optimistic despite the technical headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above recent support (¥818.7)
  • RSI indicating oversold conditions
  • Bearish MACD and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust revenue growth (8.7%) and strong cash generation
  • Low forward PE (3.9) suggesting earnings upside
  • Attractive dividend yield (2.95%) with sustainable payout

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Diversified business model across furniture, supplies, and services
  • Stable dividend policy and solid balance sheet
  • Overvaluation relative to DCF fair value indicating limited price upside

Key Metrics & Analysis

Financial Health

Revenue Growth8.70%
Profit Margin5.97%
P/E Ratio17.2
ROE8.36%
ROA4.58%
Debt/Equity1.36
P/B Ratio1.4
Op. Cash Flow¥14.4B
Free Cash Flow¥4.1B
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI32.2
Support¥818.70
Resistance¥975.00
MA 20¥883.80
MA 50¥900.34
MA 200¥886.14
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value¥436.64
Target Price¥983.33
Upside/Downside18.23%
GradeOvervalued
TypeBlend
Dividend Yield2.95%

Risk Assessment

Beta0.31
Volatility28.65%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.